About Longevity Venture Partners
Longevity Venture Partners is a venture capital firm founded in 2020. It is primarily based out of Jerusalem, Israel. As of May 2026, Longevity Venture Partners is an active investor, having invested in 18 companies, with 2 new investments in the last 12 months. It primarily invests in Seed round in Israel based startups. Its investments are spread across a wide range of sectors from HealthTech to Life Sciences and Enterprise Applications. Most recently it participated in the $***** Seed round of Uro Health A lot of funds co-invest with Longevity Venture Partners, with names like Edge Medical Ventures sharing a substantial percentage of its portfolio. Longevity Venture Partners has team of 2 people including 1 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 1 more
Deals in last 12 months
Longevity Venture Partners' List of Top Investments
Longevity Venture Partners has a portfolio of 18 companies. Their most notable investments are in Voxela and CustoMED.Their portfolio spans across United States, Israel and Canada. They have invested in HealthTech, Life Sciences, Enterprise Applications and 5 other sectors, across stages such as Seed, Series A and 1 more. Here is the list of top investments by Longevity Venture Partners:Online platform offering telehealth services. The platform enables users to select health care service based on questionnaire and schedule a telehealth visit via video or chat for the treatment of various health conditions.
Key facts about Antidote Health
- Founded Year: 2020
- Location: New York City (United States)
- Stage: Series B
- Total Funding till date: $56M
- Employee Count: 111 as on Sep 30, 2026
- Investors: iAngels, Flint Capital and 5 Others
- Latest Funding Round: Series B, Dec 18, 2024, $*****
- Highlight: Editors' Pick

2. Carefull
Online platform for expense monitoring platform for individuals. It provides accounts & credit card transactions to catch issues that may be problems, then helps you communicate, resolve them plan.
Key facts about Carefull
- Founded Year: 2019
- Location: New York City (United States)
- Stage: Series A
- Total Funding till date: $19.7M
- Employee Count: 101 as on Aug 31, 2026
- Investors: Northwestern Mutual, TTV Capital and 19 Others
- Latest Funding Round: Conventional Debt, Jun 18, 2025, $*****
- Highlight: Editors' Pick
Provider of predictive scheduling and management platform for nursing teams. It offers a platform that nursing management uses to personalize each shift to the needs of the patient by automating scheduling workflows. Utilizing past cases from triage to discharge, the machine learning based platform generates scheduling recommendations.
Key facts about In-House Health
- Founded Year: 2023
- Location: New York City (United States)
- Stage: Seed
- Total Funding till date: $5.4M
- Employee Count: 46 as on Aug 31, 2026
- Investors: New Enterprise Associates, Vine Ventures and 2 Others
- Latest Funding Round: Seed, Apr 05, 2024, $*****
- Highlight: Editors' Pick

4. Voxela
AI-powered platform for elder people. The company offers an AI-based platform to detect critical incidents such as fall, wake-up, wanderer and instantly notify caregivers about elder individuals.
Key facts about Voxela
- Founded Year: 2020
- Location: Santa Clara (United States)
- Stage: Series A
- Total Funding till date: $18.2M
- Employee Count: 14 as on Aug 31, 2026
- Investors: Sompo, Blue Heron Ventures and 10 Others
- Latest Funding Round: Series A, Sep 16, 2026, $*****
Exero is a developer of a biodegradable wireless sensor detecting anastomotic leaks in patients after a GI surgery. The sensor detects the potential of an anastomotic leak by inserting it into the colon for continuous monitoring. It alerts the physicians in case of a potential leak enabling them to take timely interventions to prevent complications.
Key facts about Exero Medical
- Founded Year: 2018
- Location: Or Yehuda (Israel)
- Stage: Seed
- Total Funding till date: $10M
- Employee Count: 19 as on Aug 31, 2026
- Investors: Tech Council Ventures, Longevity Venture Partners and 2 Others
- Latest Funding Round: Seed, Feb 13, 2025, $*****
- Highlight: Editors' Pick
Longevity Venture Partners' Year-on-Year Investment Trends
Longevity Venture Partners has invested in 18 companies over the last 5 years, with an average of 2 new investments annually in the last 5 years. In 2025, it made 5 investments, while as of May 2026, it has made 1 investment in this year. Its most recent first time investment was in Uro Health and most recent follow-on round was in Exero Medical.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 0 | 1 |
2025 | 4 | 1 | 5 |
2024 | 1 | 0 | 1 |
2023 | 0 | 0 | 0 |
2022 | 2 | 0 | 2 |
2021 | 2 | 0 | 2 |
Longevity Venture Partners' Investments by Stage
Longevity Venture Partners has made 7 investments in Seed stage with an average round size of $5.18M, 2 investments in Series A stage with an average round size of $7.5M and 1 investment in Grant (prize money) stage with an average round size of $2.7M.Stage of entry | No. of Investments |
|---|---|
Seed | 7 |
Series A | 2 |
Grant (prize money) | 1 |
Note: We have considered here, only first round of investments
Longevity Venture Partners' Investments by Sector
Longevity Venture Partners has a diverse portfolio, with companies operating in the Life Sciences, HealthTech, Consumer, Enterprise Applications and Artificial Intelligence - Industry Applications. Notably, it has invested in 17 Tech companies, 12 Software companies, 9 Enterprise (B2B) companies and at least 8 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Life Sciences | 5 |
HealthTech | 4 |
Consumer | 3 |
Enterprise Applications | 3 |
Artificial Intelligence - Industry Applications | 2 |
Others | 5 |
Note: We have considered here, only first round of investments
Longevity Venture Partners' Investments by Geography
Longevity Venture Partners has made most investments in Israel (5), followed by United States where it has made 4 investments.Country | No. of Investments |
|---|---|
Israel | 5 |
United States | 4 |
Note: We have considered here, only first round of investments
Longevity Venture Partners' recent investments
Longevity Venture Partners has made 1 investments in 2026 so far - Uro Health.Here are the most recent investments by Longevity Venture Partners:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
May 14, 2026 | - | Seed | 2859 | ||
Oct 29, 2025 | Israel | Seed | 9188 | [+3] | |
Jun 11, 2025 | Israel | Seed | 7871 | [+6] | |
Mar 14, 2025 | United States | Series A | 9373 | [+3] | |
Feb 13, 2025 | Israel | Grant (prize money) | 6984 |
Team profile of Longevity Venture Partners
Longevity Venture Partners has a team of 2 members located in Israel. Longevity Venture Partners' team does not sit on the board of any company as of now.Co-investors of Longevity Venture Partners
Over the past 5 years, 38 investors have co-invested in Longevity Venture Partners's portfolio companies. This includes funds and angels.
- Invested before Longevity Venture Partners: EIC Fund and Europa have invested in rounds before Longevity Venture Partners. There is 1 company where EIC Fund has invested before Longevity Venture Partners and 1 company where Europa has invested before Longevity Venture Partners.
- Top Co-investors of Longevity Venture Partners: 28 investors entered a company along with Longevity Venture Partners. These include investors like Edge Medical Ventures (2 companies).
- Invested after Longevity Venture Partners: A total of 8 investors have invested in Longevity Venture Partners's portfolio after their investments. Top Investors include ALL STAR SAAS FUND (1 company), Archetype Ventures (1 company) and Safie Ventures (1 company).
Recent News related to Longevity Venture Partners
•
Urologic Health Nabs $11 Million in Seed FundingMedical Product Outsourcing•Aug 03, 2026•Edge Medical Ventures, Uro Health, Scientific Health Development, Longevity Venture Partners
•
CasaPerks Technologies Raises $15.8M in Seed FundingFinSMEs•May 26, 2026•CasaPerks, Longevity Venture Partners
•
Urologic Health Secures $11M Seed Funding for Non-Invasive Urodynamics TechnologyMassinvestor•May 14, 2026•Edge Medical Ventures, Longevity Venture Partners, Scientific Health Development
•
CustoMED Secures $6M to Scale AI-Driven, Patient-Specific Orthopedic SurgeryHIT Consultant•Oct 29, 2025•CustoMED, Longevity Venture Partners, Flag Capital, Varana Capital and 4 others
•
Lembas Emerges from Stealth with Breakthrough Discovery in Natural GLP-1 for Weight Management
PR Newswire•Jun 11, 2025•FLORA Ventures, Bluestein Ventures, fresh.fund, Longevity Venture Partners and 4 others
•
Faireez Launches From Stealth With $7.5m To Transform Residential Buildings Into 5-star Hotel Experiencesintelligence360•Mar 14, 2025•Faireez, Aristagora VC, Longevity Venture Partners, Hetz Ventures and 2 others
•
Faireez Secures $7.5 Million in Seed FundingStartup Log•Mar 07, 2025•Faireez, Aristagora VC, Longevity Venture Partners, Hetz Ventures and 2 others
•
Exero Medical Closes On $12.7m Preferred Seed Financing And Establishes Us Presence To Support Clinical And Commercial Activitiesintelligence360•Feb 25, 2025•Exero Medical, Longevity Venture Partners, Tech Council Ventures, Edge Medical Ventures
•
Exero Medical scores $12.7M in funding and more digital funding newsMobiHealthNews•Feb 15, 2025•Exero Medical, Vitalchat, Cerula Care, Edge Medical Ventures and 2 others
•
Exero Medical closes on $12.7M preferred seed financing and establishes US presence to support clinical and commercial activitiesPR Newswire•Feb 13, 2025•Exero Medical, Longevity Venture Partners, Tech Council Ventures, Edge Medical Ventures



